Similar Search Results

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume I: Summary

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...

Persistent link: https://www.econbiz.de/10005763258

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume III: ACE and CCB Literature Review

Dolovich, Lisa R.; Holbrook, Anne M.; Woodruff, Margaret - Department of Economics, McMaster University - 2002

(see SEDAP 70 for abstract)

Persistent link: https://www.econbiz.de/10005763264

The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report

Grootendorst, Paul V.; Dolovich, Lisa R.; Holbrook, Anne M. - Department of Economics, McMaster University - 2002

(see SEDAP 70 for abstract)

Persistent link: https://www.econbiz.de/10005404416

The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs

Grootendorst, Paul V.; Marshall, John K.; Holbrook, Anne M. - Department of Economics, McMaster University - 2004

OBJECTIVE: To estimate the effect of differential cost sharing (DCS) schemes for non-steroidal anti-inflammatory drugs (NSAIDs) on drug subsidy program and beneficiary expenditures. DATA SOURCES/STUDY SETTING: Monthly aggregate claims data from Pharmacare, the public drug subsidy program for...

Persistent link: https://www.econbiz.de/10005404447